---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-075234"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2024-06-27T23:59:59+00:00"
generated_at: "2026-06-01T01:07:27.392939+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# TriSalus completes warrant exchange; 78.9% of public warrants tendered; warrant amendment enacted

## Summary
- 6,533,614 Public Warrants (78.89%) tendered for 0.30 shares each; settlement by July 1, 2024.
- 504,685 Private Placement Warrants (10.23%) and 0 Working Capital Warrants tendered.
- Warrant Amendment approved for Public Warrants; allows company to force conversion of remaining warrants at 0.27 shares (10% discount).
- Registration statement on Form S-4 declared effective by SEC on June 25, 2024.

## SEC filing metadata
- accession: 0001104659-24-075234
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2024-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465924075234/0001104659-24-075234-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465924075234/tm2418344d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-075234
- JSON: https://secwatch.observer/filing/0001104659-24-075234.json
- Plain text: https://secwatch.observer/filing/0001104659-24-075234.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.